These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29959696)

  • 1. Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.
    Romano S; Idolazzi C; Fava C; Fondrieschi L; Celebrano M; Delva P; Branz L; Donato A; Dalbeni A; Minuz P
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):295-301. PubMed ID: 29959696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with resistant hypertension have more peripheral arterial disease than other uncontrolled hypertensives.
    Korhonen PE; Kautiainen H; Kantola I
    J Hum Hypertens; 2015 Jan; 29(1):46-9. PubMed ID: 25078489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network.
    Mancusi C; Losi MA; Izzo R; Canciello G; Carlino MV; Albano G; De Luca N; Trimarco B; de Simone G
    Eur J Prev Cardiol; 2018 Feb; 25(3):235-243. PubMed ID: 29226693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of target organ damage and metabolic abnormalities in resistant hypertension].
    Armario P; Oliveras A; Hernández Del Rey R; Ruilope LM; De La Sierra A;
    Med Clin (Barc); 2011 Oct; 137(10):435-9. PubMed ID: 21719041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characteristics of resistant hypertension in the Brazilian population.
    Faria AP; Sabbatini AR; Coca A; Moreno H
    Arq Bras Cardiol; 2013 Jun; 100(6):579-82. PubMed ID: 23657267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of resistant hypertension in the United States, 2003-2008.
    Persell SD
    Hypertension; 2011 Jun; 57(6):1076-80. PubMed ID: 21502568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.
    Barochiner J; Alfie J; Aparicio LS; Cuffaro PE; Rada MA; Morales MS; Galarza CR; Waisman GD
    Clin Exp Hypertens; 2013; 35(6):412-7. PubMed ID: 23148480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).
    Liu K; Colangelo LA; Daviglus ML; Goff DC; Pletcher M; Schreiner PJ; Sibley CT; Burke GL; Post WS; Michos ED; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Sep; 4(9):e002275. PubMed ID: 26391135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of pseudohypertension in patients with "resistant hypertension".
    Kleman M; Dhanyamraju S; DiFilippo W
    J Am Soc Hypertens; 2013; 7(6):467-70. PubMed ID: 23849622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension].
    Hernández del Rey R; Armario P; Martín-Baranera M; Castellanos P
    Med Clin (Barc); 2006 Jul; 127(7):241-5. PubMed ID: 16942725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension.
    Esposito R; Izzo R; Galderisi M; De Marco M; Stabile E; Esposito G; Trimarco V; Rozza F; De Luca N; de Simone G
    J Hum Hypertens; 2016 Jun; 30(6):392-6. PubMed ID: 26355832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistant arterial hypertension in Primary Care patients in Spain. PRESCAP Study 2010].
    Cinza-Sanjurjo S; Alonso-Moreno FJ; Prieto-Díaz MÁ; Divisón-Garrote JA; Rodríguez-Roca GC; Llisterri-Caro JL;
    Semergen; 2015 Apr; 41(3):123-30. PubMed ID: 24768029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
    BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.